Z-Medica Announces Appointment of Eric Compton as CEO
WALINGFORD, Conn. (PRWEB) February 27, 2018 -- Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces today the appointment of healthcare industry veteran Eric Compton as President and Chief Executive Officer effective March 5, 2018. Outgoing CEO Stephen J. Fanning is stepping down to pursue a new career opportunity that will allow him to be closer to his family and home on the West Coast. Mr. Fanning will continue to serve as a member of the Z-Medica Board.
“We are incredibly excited by Eric’s appointment to Z-Medica. His deep healthcare experience, strong leadership skills and passion for growth will continue to drive Z-Medica to even greater success. We also wish Steve the very best in his future endeavors and thank him for his great leadership and contribution in building Z-Medica into the outstanding hemostatic products business it is today.” said Z-Medica Board Chairman and Linden Operating Partner, Ernest Waaser.
“I am extremely honored to be taking over the reins of Z-Medica,” said Compton. “Recently, Z-Medica has made considerable investments to upgrade their internal operating systems and substantially increase their U.S. and international sales force as well as hiring additional support staff at the headquarters in Wallingford. I look forward to building on that current momentum and accelerating our growth even further.”
Mr. Compton most recently served as Chief Operating Officer of Hologic where he made significant contributions to the growth and profitability of the company. He began his career at Procter & Gamble and later joined Johnson & Johnson where he progressed through a series of positions of increasingly greater responsibility in their Consumer and Medical Device businesses.
Mr. Compton is the former Chairman of the AdvaMedDX Board of Directors, holds a Master of Business Administration degree from Kennesaw State University and a Bachelor of Arts degree from the University of Richmond.
About Z-Medica, LLC
Z-Medica, LLC, a Linden Capital Partners portfolio company, is a medical device manufacturer based in Wallingford, CT that is focused on the development, sale and marketing of innovative hemorrhage control products. For over a decade, Z-Medica has helped hospitals, militaries, law enforcement, first responders and consumers around the globe save lives and improve medical outcomes with their QuikClot® brand of products which are manufactured in the United States. For more information, please visit http://www.Z-Medica.com.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit http://www.lindenllc.com.
Dave Schemelia, Tiberend Strategic Advisors, +1 (609) 468-9325, [email protected]
Share this article